These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31548894)

  • 1. Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.
    Nkwopara E; Schmicker R; Mvalo T; Phiri M; Phiri A; Couasnon M; McCollum ED; Ginsburg AS
    BMJ Open Respir Res; 2019; 6(1):e000415. PubMed ID: 31548894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi.
    Ginsburg AS; May S
    Sci Rep; 2022 Mar; 12(1):3538. PubMed ID: 35241775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
    N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.
    Nkwopara E; Schmicker R; Mvalo T; May S; Ginsburg AS
    BMJ Open Respir Res; 2019; 6(1):e000414. PubMed ID: 31179007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
    Jehan F; Nisar I; Kerai S; Balouch B; Brown N; Rahman N; Rizvi A; Shafiq Y; Zaidi AKM
    N Engl J Med; 2020 Jul; 383(1):24-34. PubMed ID: 32609980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
    Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
    PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol improves efficacy of oral amoxicillin against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical trial.
    Qiang L; Di Y; Jiang Z; Xu J
    Microb Pathog; 2018 Jan; 114():209-212. PubMed ID: 29198820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
    Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
    BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1758-1766. PubMed ID: 25842223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
    Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S
    Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based amoxicillin treatment for fast breathing pneumonia in young infants 7-59 days old: a cluster randomised trial in rural Bangladesh, Ethiopia, India and Malawi.
    ; Nisar YB
    BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34417274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
    Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
    J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.
    Tikmani SS; Muhammad AA; Shafiq Y; Shah S; Kumar N; Ahmed I; Azam I; Pasha O; Zaidi AK
    Clin Infect Dis; 2017 Jan; 64(2):184-189. PubMed ID: 27941119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.